anonymous
Guest
anonymous
Guest
Person who posted the post before this one is an idiot. Jazz is a company full of rejects.
Person who posted the post before this one is an idiot. Jazz is a company full of rejects.
Have you seen the year end results for Jazz, and more specifically Defitelio and Erwinaze? Yes, supply issues are concerning but with that challenge, sales were down 1% Yoy and actually up in Q4. Defitelio exceeded expectations for the year. I am not familiar with what he has done in the past, however, with your comments based mostly on his physical stature, I can only assume you are a surface view or shallow person. No one is holding a gun to your head to stay. Lots of opportunities out there. I'm sure with your attitude, your manager won't miss you either.
Have you seen the year end results for Jazz, and more specifically Defitelio and Erwinaze? Yes, supply issues are concerning but with that challenge, sales were down 1% Yoy and actually up in Q4. Defitelio exceeded expectations for the year. I am not familiar with what he has done in the past, however, with your comments based mostly on his physical stature, I can only assume you are a surface view or shallow person. No one is holding a gun to your head to stay. Lots of opportunities out there. I'm sure with your attitude, your manager won't miss you either.
Even with supply fiasco we were still up. David is a driving force in the company and the defitelio and erwinaze hold proved he can overcome any obstacle. Santos's is incredibly well liked by his peers so don't fall for the malice by former disgruntled employees.
Dave's departure is a loss for the team - his leadership and passion will be missed. And his broad and deep Onc experience will not be easily replaced.
Dave's departure is a loss for the team - his leadership and passion will be missed. And his broad and deep Onc experience will not be easily replaced.